PerrigoPRGO
Market Cap: $3.69B
About: Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Employees: 9,140
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
626% more call options, than puts
Call options by funds: $65.8M | Put options by funds: $9.07M
0% less funds holding
Funds holding: 356 [Q1] → 355 (-1) [Q2]
0.99% less ownership
Funds ownership: 96.04% [Q1] → 95.05% (-0.99%) [Q2]
2% less first-time investments, than exits
New positions opened: 52 | Existing positions closed: 53
10% less repeat investments, than reductions
Existing positions increased: 122 | Existing positions reduced: 136
21% less capital invested
Capital invested by funds: $4.19B [Q1] → $3.33B (-$861M) [Q2]
31% less funds holding in top 10
Funds holding in top 10: 13 [Q1] → 9 (-4) [Q2]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
Piper Sandler Korinne Wolfmeyer 33% 1-year accuracy 13 / 39 met price target | 29%upside $35 | Overweight Maintained | 11 Jul 2024 |
Financial journalist opinion
Based on 4 articles about PRGO published over the past 30 days